Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Als: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting motor neurons in the brain and spinal cord. ALS leads to muscle weakness, atrophy, and eventual paralysis. Key genetic factors include mutations in SOD1, C9orf72, TDP-43, and FUS. Pathological mechanisms involve protein aggregation, RNA metabolism dysfunction, mitochondrial impairment, excitotoxicity, and neuroinflammation. The disease has a median survival of 3-5 years from symptom onset.
| Synaptogenesis | Release of thrombospondins and other synaptogenic factors |
| Synaptic Pruning | Participation in developmental synapse elimination |
| Neurotransmitter Recycling | Conversion of glutamate to glutamine via glutamine synthetase |
| Associated Genes | MAP6, HCN1, HCN4, HCN2, RASA1, EPHB4, HSPA1B, AGER |
| Therapeutic Agents | Riluzole, Arimoclomol |
| KG Connections | 9930 knowledge graph edges |
| Databases | OMIMOrphanetClinicalTrialsPubMed |
Knowledge base pages for this entity
graph TD
subgraph Therapeutic["Therapeutic"]
Als["Als"] -->|"therapeutic target"| Wnt["Wnt"]
Als["Als"] -->|"therapeutic target"| Apoptosis["Apoptosis"]
JUN["JUN"] -->|"therapeutic target"| Als["Als"]
end
subgraph Signaling["Signaling"]
Als["Als"] -->|"activates"| Glycolysis["Glycolysis"]
Als["Als"] -.->|"inhibits"| Mtor["Mtor"]
Als["Als"] -->|"activates"| Complement["Complement"]
Als["Als"] -->|"activates"| Phagocytosis["Phagocytosis"]
Als["Als"] -->|"activates"| Nf__b["Nf-Kappab"]
GAIN["GAIN"] -->|"activates"| Als["Als"]
MTOR["MTOR"] -.->|"inhibits"| Als["Als"]
APOE["APOE"] -.->|"inhibits"| Als["Als"]
JUN_1["JUN"] -->|"activates"| Als["Als"]
end
subgraph Interactions["Interactions"]
Als["Als"] -->|"interacts with"| Autophagy["Autophagy"]
LC3["LC3"] -->|"interacts with"| Als["Als"]
end
subgraph Pathology["Pathology"]
Als["Als"] -->|"associated with"| Neuroinflammation["Neuroinflammation"]
end
style Als fill:#ef5350,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
style Wnt fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Glycolysis fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Autophagy fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Mtor fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Complement fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Phagocytosis fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Nf__b fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Neuroinflammation fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Apoptosis fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style JUN fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style GAIN fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style LC3 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style MTOR fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style APOE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style JUN_1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Wnt | therapeutic_target | pathway | 1.00 |
| Glycolysis | activates | pathway | 1.00 |
| Autophagy | interacts_with | pathway | 1.00 |
| Mtor | inhibits | pathway | 1.00 |
| Complement | activates | pathway | 1.00 |
| Phagocytosis | activates | pathway | 1.00 |
| Nf-Κb | activates | pathway | 1.00 |
| Neuroinflammation | associated_with | disease | 1.00 |
| Apoptosis | therapeutic_target | pathway | 1.00 |
| Angiogenesis | activates | pathway | 1.00 |
| Immune Response | activates | pathway | 1.00 |
| Oxidative Stress | activates | pathway | 1.00 |
| Epigenetic | therapeutic_target | pathway | 1.00 |
| Autophagy | therapeutic_target | pathway | 1.00 |
| Oxidative Stress | regulates | pathway | 1.00 |
| Amyotrophic Lateral Sclerosis | associated_with | disease | 1.00 |
| Cardiovascular | associated_with | disease | 1.00 |
| Autophagy | associated_with | pathway | 1.00 |
| Mtor | interacts_with | pathway | 1.00 |
| Alzheimer | associated_with | disease | 1.00 |
| Innate Immunity | activates | pathway | 1.00 |
| Inflammation | associated_with | disease | 1.00 |
| Mtor | associated_with | pathway | 1.00 |
| Autophagy | activates | pathway | 1.00 |
| Innate Immunity | regulates | pathway | 1.00 |
| Epigenetic | regulates | pathway | 1.00 |
| Epigenetic | activates | pathway | 1.00 |
| Mtor | activates | pathway | 1.00 |
| Blood-Brain Barrier | therapeutic_target | pathway | 1.00 |
| Multiple Sclerosis | associated_with | disease | 1.00 |
| Mitochondrial Function | activates | pathway | 1.00 |
| Lipid Metabolism | regulates | pathway | 1.00 |
| Atherosclerosis | associated_with | disease | 1.00 |
| Blood-Brain Barrier | inhibits | pathway | 1.00 |
| Lipid Metabolism | activates | pathway | 1.00 |
| Wnt | activates | pathway | 1.00 |
| Ferroptosis | associated_with | pathway | 1.00 |
| Ferroptosis | inhibits | pathway | 1.00 |
| Complement | therapeutic_target | pathway | 1.00 |
| Autophagy | inhibits | pathway | 1.00 |
| Proteasome | activates | pathway | 1.00 |
| Blood-Brain Barrier | activates | pathway | 1.00 |
| Ubiquitin-Proteasome | activates | pathway | 1.00 |
| Mitochondrial Function | regulates | pathway | 1.00 |
| Ferroptosis | regulates | pathway | 1.00 |
| Longevity | associated_with | disease | 1.00 |
| Dna Methylation | associated_with | pathway | 1.00 |
| Epigenetic | associated_with | pathway | 1.00 |
| Angiogenesis | therapeutic_target | pathway | 1.00 |
| Apoptosis | activates | pathway | 1.00 |
| Source | Relation | Type | Str |
|---|---|---|---|
| JUN | therapeutic_target | gene | 1.00 |
| GAIN | activates | gene | 1.00 |
| LC3 | interacts_with | gene | 1.00 |
| MTOR | inhibits | gene | 1.00 |
| APOE | inhibits | gene | 1.00 |
| JUN | activates | gene | 1.00 |
| OPTN | interacts_with | gene | 1.00 |
| MTOR | interacts_with | gene | 1.00 |
| CGAS | activates | gene | 1.00 |
| STING | activates | gene | 1.00 |
| SQSTM1 | associated_with | gene | 1.00 |
| SOD1 | associated_with | gene | 1.00 |
| MTOR | associated_with | gene | 1.00 |
| MYC | activates | gene | 1.00 |
| TNF | expressed_in | gene | 1.00 |
| APOE | regulates | gene | 1.00 |
| GPX4 | inhibits | gene | 1.00 |
| BECN1 | activates | gene | 1.00 |
| IL6 | therapeutic_target | gene | 1.00 |
| PIEZO1 | activates | gene | 1.00 |
| APOE | therapeutic_target | gene | 1.00 |
| APOE | activates | gene | 1.00 |
| APOE | associated_with | gene | 1.00 |
| TREM2 | activates | gene | 1.00 |
| BAX | inhibits | gene | 1.00 |
| LC3 | associated_with | gene | 1.00 |
| MTOR | therapeutic_target | gene | 1.00 |
| PINK1 | activates | gene | 1.00 |
| LC3 | activates | gene | 1.00 |
| MTOR | activates | gene | 1.00 |
| PTEN | activates | gene | 1.00 |
| TBK1 | activates | gene | 1.00 |
| OVERVIEW | regulates | gene | 1.00 |
| PARKIN | regulates | gene | 1.00 |
| PINK1 | regulates | gene | 1.00 |
| GAPDH | activates | gene | 1.00 |
| SQSTM1 | activates | gene | 1.00 |
| TNF | activates | gene | 1.00 |
| BDNF | activates | gene | 1.00 |
| SIRT1 | regulates | gene | 1.00 |
| NRF2 | therapeutic_target | gene | 1.00 |
| EGFR | associated_with | gene | 1.00 |
| MAP1LC3B | activates | gene | 1.00 |
| GPX4 | activates | gene | 1.00 |
| SLC7A11 | activates | gene | 1.00 |
| SOD1 | therapeutic_target | gene | 1.00 |
| C9ORF72 | associated_with | gene | 1.00 |
| OPTN | associated_with | gene | 1.00 |
| TNF | inhibits | gene | 1.00 |
| MTOR | regulates | gene | 1.00 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Stathmin-2 Splice Switching to Prevent Axonal Degeneration A | 0.664 | neurodegeneration | RNA binding protein dysregulation across |
| Microglial AIM2 Inflammasome as the Primary Driver of TDP-43 | 0.601 | neurodegeneration | What are the mechanisms by which gut mic |
| PIKFYVE Inhibition Activates Aggregate Exocytosis via PI(3,5 | 0.559 | neurodegeneration | How does PIKFYVE inhibition activate unc |
| C9orf72-SMCR8-WDR41 Complex Dysfunction in C9-ALS Rescued by | 0.537 | neurodegeneration | How does PIKFYVE inhibition activate unc |
Scientific analyses that reference this entity
neurodevelopment | 2026-04-15 | 1 hypotheses Top: 0.576
neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.455
neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.548
neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.604
neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.606
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||